Tim Jaeger has been the Lifecycle Leader for the RMD virology business since 2013. He is responsible for preparing and implementing the RMD virology strategy, covering areas like HIV, hepatitis and transplantation, to ensure we maintain and grow our global leadership position. HIV is the world's leading infectious killer, affecting more than 35 million people. Yet, less than half actually know that they are infected.
Of those who know their positive status, only 38 percent actually receive treatment and less than 50 percent on treatment have access to viral load testing to monitor their treatment outcomes.
It's time to assess where we as a society are in the fight against HIV and to look ahead toward even better strategies that can improve treatment and global access to support the Joint United Nations Program on HIV and AIDS (UNAIDS) call to action that by 2020, 90 percent of all people living with HIV know their status, 90 percent of all people diagnosed with HIV receive antiretroviral therapy, and 90 percent of all people receiving HIV treatment are virally suppressed.
What types of strategies are there that can improve diagnosis and global access?
Listen in as Tim Jaeger, MD, PhD, MBA, shares the latest information on HIV/AIDS and the strategies that are being used to help fight the virus.
Health Topics A-Z
Improving Treatment & Global Access to Fight HIV
Guest
: Tim Jaeger, MD, PhD, MBA
From the Show: Health Radio
Summary: HIV is the world's leading infectious killer, affecting more than 35 million people. Yet, less than half actually know that they are infected.
Air Date: 12/3/15
Duration: 10
Host: Melanie Cole, MS
Tagged under